HALO logo
halo search icon
Mirum Pharmaceuticals, Inc.

US$96.95

Price Change Indicator
1.30 (1.36%)
Mirum Pharmaceuticals, Inc.
MIRM · NAS

Mirum Pharmaceuticals, Inc.

Start Trading MIRM for Free

US$96.95

Price Arrow1.30 (1.36%)
20/05/2026 04:00:01 PM
All-CompaniesAll-ConsensusHALO All
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Mirum Pharmaceuticals, Inc. Overview

MIRM Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Neutral

Earnings

Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About MIRM

icon
icon

Telephone

1.650.667.4085

icon

Address

Suite 300, 989 East Hillsdale Boulevard, Foster City, CA 94404

Description

Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The firm focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. Its products include Maralixibat and Volixibat. The company was founded by Niall O'Donnel, Michael Grey and Christopher Peetz in May 2018 and is headquartered in Foster City, CA.

MIRM Price Chart

Key Stats

Market Cap

US$5.83B

PE

0.00

EV/EBITDA

1,846.1

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 42.89 - 114.99

Trade Value (12mth)

US$14,984,774.00

1 week

-6.4%

1 month

2.49%

YTD

22.52%

1 year

115.87%

All time high

114.99

Key Fundamentals

EPS 3 yr Growth

-88.40%

EBITDA Margin

0.40%

Operating Cashflow

$56m

Free Cash Flow Return

9.50%

ROIC

-4.00%

Interest Coverage

0.10

Quick Ratio

2.60

Other Data

Shares Outstanding (Fully Diluted)

59m

HALO Sector

Healthcare

Next Company Report Date

10-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

MIRM Announcements

Latest Announcements

DateAnnouncements
19 May 26
19 May 26
07 May 26
07 May 26
07 May 26

MIRM Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-4-1.85-0.47locklocklock
EPS (Fully Diluted)
 $locklocklocklock-4-1.85-0.47locklocklock
Growth
 %locklocklocklock0.353.774.9locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/A1,846.1locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Mirum Pharmaceuticals, Inc. (MIRM:NAS)?
Halo FAQ
The current share price of Mirum Pharmaceuticals, Inc. (MIRM:NAS) is USD$96.95.
What is the 52-week high share price for Mirum Pharmaceuticals, Inc. (MIRM:NAS)?
Halo FAQ
The 52-week high share price for Mirum Pharmaceuticals, Inc. (MIRM:NAS) is USD$114.99.
What is the 52-week low share price for Mirum Pharmaceuticals, Inc. (MIRM:NAS)?
Halo FAQ
The 52-week low share price for Mirum Pharmaceuticals, Inc. (MIRM:NAS) is USD$42.89.
What is the dividend yield for Mirum Pharmaceuticals, Inc. (MIRM:NAS)?
Halo FAQ
Mirum Pharmaceuticals, Inc. (MIRM:NAS) does not pay a dividend.
What was Mirum Pharmaceuticals, Inc. (MIRM:NAS) last dividend payment?
Halo FAQ
Mirum Pharmaceuticals, Inc. (MIRM:NAS) does not pay a dividend.
What is the franking level for Mirum Pharmaceuticals, Inc. (MIRM:NAS)?
Halo FAQ
Mirum Pharmaceuticals, Inc. (MIRM:NAS) has a franking level of 0.00%.
In which sector is Mirum Pharmaceuticals, Inc. (MIRM:NAS) classified?
Halo FAQ
Mirum Pharmaceuticals, Inc. (MIRM:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial